BIOVERIC Pharmaceuticals, Inc.

We are developing new drug products with dosage form innovation for patients with unmet needs. Our pipeline includes drug product candidates with promising market and potential intellectual property. We are focused to design and develop innovative drug products to revolutionize drug delivery for better patient outcome. We use 505(b)(2) regulatory pathway, enabling quicker and more cost-effective approvals by utilizing FDA’s finding for safety and efficacy of the drugs. Our mission is to create a world where every patient is treated conveniently with safe and effective medicines. Our vision is to specialize in patient-centric innovative drug delivery.